** Pharmaceutical stocks slide 1.8% after U.S. President Donald Trump signals "major" tariff on pharma imports soon
** Nifty Pharma .NIPHARM index down 6.3% since April 4 when Trump first threatened the duties, ending the sector's brief reprieve
** According to Trump, the pharma duty will incentivise drug cos to move operations to the U.S.
** NIPHARM's all 20 constituents in the red; Gland Pharma GLAD.NS, Dr Reddy's Laboratories REDY.NS, Lupin LUPN.NS, IPCA Laboratories IPCA.NS lose between 2%-4.3%
** Sub-index extends YTD losses to 14.4% vs Nifty 50's .NSEI 5.1% fall
(Reporting by Aleef Jahan in Bengaluru)
((aleefjahan.cs@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.